CACrown ArchivesThe cinema collection
Menu
Research dossier · General Reference

Estrogenic substances

estrogen medication

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionSep 10, 2026
Entity authorityQ85759680 ↗
Source-derived summary

Estrogenic substances, also referred to as natural estrogens and sold under the brand name Amniotin among others, is an estrogen medication which was marketed in the 1930s and 1940s and is no longer available. It was a purified extract of animal material such as horse urine, placenta, and/or amniotic fluid, and contained a non-crystalline mixture of estrogens, including estrone, 17β-estradiol, 17α-estradiol, and/or equilin. The medication was thought to contain estrone as its major active ingredient and was described as an estrone-like preparation, or as "essentially estrone". Estrogenic substances was originally produced from the urine of pregnant women, placenta, and/or amniotic fluid, but by the early 1940s, it was manufactured exclusively from the urine of stallions or pregnant mares, similarly to almost all other estrogen preparations on the market.

Estrogenic substances was marketed under a variety of different brand names including Amniotin (Squibb), Equine Estrogenic Substances (Ayerst), Estrogenic Hormones (Upjohn, others), Estrogenic Substances (Reed & Carnrick, Sharp & Dohme, others), Estrolin (Lakeside), Estromone, Estronat (National Drug), Folestrin (Armour), Follacro (Schieffelin), Menformon (Roche-Organon), Neo-Amniotin (Squibb), Oestroform, Ova-Estrin, Theelestrin, and Urestrin (Upjohn), among others. It was provided in various forms and routes of administration including oil solution and aqueous suspension for intramuscular injection, oral tablets and capsules, vaginal suppositories, and topical ointments.

Estrogen medications similar to but distinct from estrogenic substances included conjugated estriol (Emmenin) and conjugated estrogens (Premarin). They are also non-crystalline mixtures of estrogens. Estrogenic substances were also distinct from pure crystalline preparations such as estrone, estradiol, estriol, estradiol benzoate, and estradiol dipropionate. The medication should additionally be distinguished from estrogen ovarian extracts, which had little activity and were considered to be essentially inactive.

Editorial summary

“Estrogenic substances” enters the record as estrogen medication. Crown Archives preserves that source wording while asking what Estrogenic, substances and estrogen can confirm, complicate or overturn.

Editorial reviewA dependable orientation record for establishing vocabulary, names and a first evidence trail. The current 273-word lead offers orientation but no explicit four-digit date, so chronology should not be assumed. The selected authority fields contribute no independent date. Its strongest next move is a source search built around Estrogenic, substances and estrogen.
Editorial analysis

Why this record matters

“Estrogenic substances” is worth following because a concise public description often conceals a longer documentary argument. Here, Estrogenic, substances and estrogen provides the most credible route into that argument.

Evidence profile

The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Sep 10, 2026. The linked authority identifier is Q85759680. None of the 0 selected statements returned an explicit reference.

Critical limits

The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “Estrogenic substances”, its source revision and the description used here.
  2. Expand the search: follow Estrogenic substances primary sources, Estrogenic substances archive and Estrogenic research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Estrogenic substances”?
  2. Which institution is responsible for the underlying evidence?
  3. What terminology or title could unlock a more precise catalogue search?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “Estrogenic substances” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.